LISATA THERAPEUTICS, INC.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On February 24, 2022, Todd C. Girolamo, Esq., Chief Legal Officer, Senior Vice President of Corporate Development and Corporate Secretary of Caladrius Biosciences, Inc. (the “Company”), notified the Company of his intent to resign from all positions held with the Company in order to pursue other career opportunities.
Extracted from this filing and checked against the source text.
Todd C. Girolamo resigned as Chief Legal Officer at LISATA THERAPEUTICS, INC..
On February 24, 2022, Todd C. Girolamo, Esq., Chief Legal Officer, Senior Vice President of Corporate Development and Corporate Secretary of Caladrius Biosciences, Inc. (the “Company”), notified the Company of his intent to resign from all positions held with the Company in order to pursue other career opportunities.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.